Switch to:

Corvus Pharmaceuticals Price-to-Free-Cash-Flow

: (As of Today)
View and export this data going back to 2016. Start your Free Trial

As of today (2020-10-23), Corvus Pharmaceuticals's share price is $4.00. Corvus Pharmaceuticals's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2020 was $-1.29. Hence, Corvus Pharmaceuticals's Price-to-Free-Cash-Flow Ratio for today is .

Corvus Pharmaceuticals's Free Cash Flow per Share for the three months ended in Jun. 2020 was $-0.32. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-1.29.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 13.30% per year.

During the past 6 years, Corvus Pharmaceuticals's highest 3-Year average Free Cash Flow per Share Growth Rate was 13.30% per year. The lowest was -32.90% per year. And the median was -9.80% per year.


Corvus Pharmaceuticals Price-to-Free-Cash-Flow Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Corvus Pharmaceuticals Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Price-to-Free-Cash-Flow Premium Member Only 0.00 0.00 0.00 0.00 0.00

Corvus Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Corvus Pharmaceuticals Price-to-Free-Cash-Flow Distribution

* The bar in red indicates where Corvus Pharmaceuticals's Price-to-Free-Cash-Flow falls into.



Corvus Pharmaceuticals Price-to-Free-Cash-Flow Calculation

Corvus Pharmaceuticals's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=4.00/-1.291
=

Corvus Pharmaceuticals's Share Price of today is $4.00.
Corvus Pharmaceuticals's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2020 was -0.361 (Sep. 2019 ) + -0.29 (Dec. 2019 ) + -0.318 (Mar. 2020 ) + -0.322 (Jun. 2020 ) = $-1.29.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Corvus Pharmaceuticals  (NAS:CRVS) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Corvus Pharmaceuticals Price-to-Free-Cash-Flow Related Terms


Corvus Pharmaceuticals Price-to-Free-Cash-Flow Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)